In gastric cancers or other cancers dependent on PI3K/Akt signaling, CBS is often epigenetically silenced or downregulated, thus preventing cells from senescence maintenance and regaining the proliferative capacity to drive cancer development [89]. This evidence concerns the gene CBS and cancer.